Examining Cesarean Section Rates in Canada Using the Modified Robson Classification.


Journal

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
ISSN: 1701-2163
Titre abrégé: J Obstet Gynaecol Can
Pays: Netherlands
ID NLM: 101126664

Informations de publication

Date de publication:
06 2020
Historique:
received: 27 05 2019
revised: 06 09 2019
accepted: 09 09 2019
pubmed: 31 12 2019
medline: 1 7 2021
entrez: 30 12 2019
Statut: ppublish

Résumé

Canada's cesarean delivery (CD) rate continues to increase. The Society of Obstetricians and Gynaecologists of Canada advocates the use of the modified Robson classification for comparisons. This study describes national and provincial CD rates according to this classification system. All 2016-2017 in-hospital births in Canada (outside Québec) reported to the Discharge Abstract Database were categorized using the modified Robson classification system. CD rates, group size, and contributions of each group to the overall volume of CD were reported. Rates by province and hospital peer group were also examined (Canadian Task Force Classification III). A total of 286 201 women gave birth; among these, 83 262 (29.1%) had CDs. Robson group 5 (term singleton previous CD) had a CD rate of 80.5% and was the largest contributing group to the overall number of CD (36.6%). Women whose labour was induced (Robson group 2A) had a CD rate almost double the rate of women with spontaneous labour (Robson group 1): 33.5% versus 18.4%. These latter two groups made the next largest contributions to overall CD (15.7% and 14.1%, respectively). There were substantial variations in CD rates across provinces and among hospital peer groups. The study found large variations in CD rates across provinces and hospitals within each Robson group, thus suggesting that examining variations to determine the groups contributing the most to CD rates (Robson groups 5, 2A, and 1) may provide valuable insight for reducing CD rates. This study provides a benchmark for measuring the impact of future initiatives to reduce CD rates in Canada.

Identifiants

pubmed: 31883751
pii: S1701-2163(19)30831-X
doi: 10.1016/j.jogc.2019.09.009
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

757-765

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Jing Gu (J)

Canadian Institute for Health Information, Toronto, ON.

Sunita Karmakar-Hore (S)

Canadian Institute for Health Information, Toronto, ON.

Mary-Ellen Hogan (ME)

Canadian Institute for Health Information, Toronto, ON.

Hussam M Azzam (HM)

Queen Elizabeth Hospital, Charlottetown, PEI; Department of Obstetrics and Gynaecology, Dalhousie University, Halifax, NS; Department of Obstetrics and Gynaecology, University of Manitoba, Winnipeg, MB.

Jon F R Barrett (JFR)

Sunnybrook Health Sciences Centre, Toronto, ON.

Adrian Brown (A)

Department of Obstetrics and Gynaecology, North York General Hospital, Toronto, ON; Department of Obstetrics and Gynaecology, University of Toronto, Toronto, ON.

Jocelynn L Cook (JL)

Society of Obstetricians and Gynaecologists of Canada, Ottawa, ON; Department of Obstetrics and Gynaecology, University of Ottawa, Ottawa, ON.

Venu Jain (V)

Department of Obstetrics and Gynaecology, University of Alberta, Edmonton, AB.

Nir Melamed (N)

Sunnybrook Health Sciences Centre, Toronto, ON; Department of Obstetrics and Gynaecology, University of Toronto, Toronto, ON.

Graeme N Smith (GN)

Department of Obstetrics and Gynaecology, Queen's University, Kingston, ON.

Arthur Zaltz (A)

Sunnybrook Health Sciences Centre, Toronto, ON; Department of Obstetrics and Gynaecology, University of Toronto, Toronto, ON.

Yana Gurevich (Y)

Canadian Institute for Health Information, Toronto, ON. Electronic address: ygurevich@cihi.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH